We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $5.49B
1-Year Est. Return 46.89%
This Fund
S&P 500
This Quarter Est. Return
+8.31%
1 Year Est. Return
+46.89%
3 Year Est. Return
+94.27%
5 Year Est. Return
+129.04%
10 Year Est. Return
+529.98%
AUM
$4.49B
AUM Growth
+$923M
Cap. Flow
+$365M
Cap. Flow %
8.12%
Top 10 Hldgs %
65.14%
Holding
61
New
18
Increased
19
Reduced
10
Closed
7
Avg Time Held Equity + Options
8 quarters
Top 10 Avg Time Held Equity + Options
8 quarters
Top 20 Avg Time Held Equity + Options
7.4 quarters
Avg Time Held Equity only
8.1 quarters
Top 10 Avg Time Held Equity only
8.1 quarters
Top 20 Avg Time Held Equity only
7.8 quarters

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$85.2M
2
Z icon
Zillow
Z
+$72.7M
3
GPN icon
Global Payments
GPN
+$69.5M
4
ICLR icon
Icon
ICLR
+$62.2M
5
DHR icon
Danaher
DHR
+$42.7M

Top Sells

Rank Stock Value
1
THC icon
Tenet Healthcare
THC
+$108M
2
META icon
Meta Platforms (Facebook)
META
+$77.7M
3
CI icon
Cigna
CI
+$54.5M
4
WDC icon
Western Digital
WDC
+$38.4M
5
EXPE icon
Expedia Group
EXPE
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 49.55%
2 Technology 13.23%
3 Industrials 11.63%
4 Consumer Discretionary 8.86%
5 Miscellaneous 8.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CVS icon
1
CVS Health
CVS
$112B
$618M 13.76%
8,196,799
– –
2023 Q4
7 quarters
THC icon
2
Tenet Healthcare
THC
$21.5B
$472M 10.5%
2,323,679
-606,326
-21% -$108M
2013 Q2
49 quarters
GPN icon
3
Global Payments
GPN
$21.7B
$427M 9.51%
5,141,892
+825,000
+19% +$69.5M
2020 Q4
19 quarters
SPY icon
4
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$378M 8.4%
+566,700
New +$363M
2025 Q3
0 quarters
TEVA icon
5
Teva Pharmaceutical Industries Limited
TEVA
$48.1B
$337M 7.51%
16,692,680
+868,457
+5% +$15.3M
2023 Q4
7 quarters
GTM icon
6
ZoomInfo Technologies
GTM
$1.15B
$202M 4.49%
18,505,242
+2,123,843
+13% +$22.8M
2024 Q2
5 quarters
AMZN icon
7
Amazon
AMZN
$2.79T
$143M 3.19%
652,138
+89,264
+16% +$20.2M
2023 Q1
10 quarters
TMO icon
8
Thermo Fisher Scientific
TMO
$245B
$137M 3.05%
282,941
+182,941
+183% +$85.2M
2025 Q2
1 quarter
DXC icon
9
DXC Technology
DXC
$2.04B
$114M 2.53%
8,339,897
+2,473,350
+42% +$35.1M
2017 Q2
33 quarters
UHS icon
10
Universal Health Services
UHS
$10.6B
$98.6M 2.19%
482,169
+92,692
+24% +$16.7M
2022 Q4
11 quarters
PYPL icon
11
PayPal
PYPL
$48.1B
$89.4M 1.99%
1,333,370
+327,226
+33% +$23.1M
2025 Q1
2 quarters
VTRS icon
12
Viatris
VTRS
$19.8B
$81.7M 1.82%
8,247,584
– –
2023 Q4
7 quarters
USFD icon
13
US Foods
USFD
$21.2B
$81.6M 1.82%
1,065,329
-313,552
-23% -$24.9M
2021 Q4
15 quarters
DKS icon
14
Dick's Sporting Goods
DKS
$13.6B
$78.1M 1.74%
351,601
+61,069
+21% +$13.3M
2025 Q2
1 quarter
EXPE icon
15
Expedia Group
EXPE
$32.8B
$76.9M 1.71%
359,793
-148,463
-29% -$29.8M
2022 Q3
12 quarters
Z icon
16
Zillow
Z
$6.29B
$68.5M 1.53%
+889,666
New +$72.7M
2025 Q3
0 quarters
ALIT icon
17
Alight
ALIT
$243M
$66.4M 1.48%
1,018,889
-200,227
-16% -$17.7M
2022 Q3
12 quarters
ICLR icon
18
Icon
ICLR
$12.7B
$65M 1.45%
+371,418
New +$62.2M
2025 Q3
0 quarters
MRVL icon
19
Marvell Technology
MRVL
$242B
$56.9M 1.27%
676,980
+269,968
+66% +$19.9M
2025 Q1
2 quarters
UAL icon
20
United Airlines
UAL
$33.5B
$56.2M 1.25%
582,009
+13,147
+2% +$1.26M
2025 Q1
2 quarters
ESI icon
21
Element Solutions
ESI
$9.07B
$55.6M 1.24%
2,207,167
-608,879
-22% -$15.2M
2016 Q3
36 quarters
SGRY icon
22
Surgery Partners
SGRY
$1.9B
$55.1M 1.23%
2,546,735
+1,017,510
+67% +$22.7M
2025 Q2
1 quarter
CI icon
23
Cigna
CI
$74.7B
$54.1M 1.2%
187,757
-184,136
-50% -$54.5M
2013 Q2
49 quarters
DHR icon
24
Danaher
DHR
$157B
$52.4M 1.17%
264,418
+214,418
+429% +$42.7M
2025 Q2
1 quarter
UBER icon
25
Uber
UBER
$146B
$46.2M 1.03%
471,801
+205,130
+77% +$19.2M
2021 Q2
17 quarters
1
2 3

Similar funds

GCM
Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MC
Maplelane Capital New York $5.51B AUM 67.92% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Glenview Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Glenview Capital Management held 61 positions worth $4.49B, up 26% from $3.57B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Glenview Capital Management deployed $365M of net new capital in Q3 2025, opening 18 new positions and adding to 19 existing holdings. Its largest new stake was Zillow: 889,666 shares worth $68.5M.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, down from 51% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Tenet Healthcare, an estimated $108M trimmed.

  • Glenview Capital Management's largest Q3 2025 buy was Zillow: 889,666 shares worth $68.5M.
  • Glenview Capital Management added most to Thermo Fisher Scientific in Q3 2025, an estimated $85.2M increase.
  • Glenview Capital Management's biggest Q3 2025 reduction was Tenet Healthcare, cutting an estimated $108M.
  • Glenview Capital Management fully exited Western Digital in Q3 2025, selling an estimated $38.4M.
  • Glenview Capital Management's ten largest holdings make up 65% of its $4.49B portfolio in Q3 2025.
  • Glenview Capital Management opened 18 new positions and closed 7 in Q3 2025.
  • Glenview Capital Management's portfolio value rose 26% quarter-over-quarter to $4.49B.

Based on Glenview Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.